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The two mouse melanoma cell lines Bl6-Fl and B16-G4F retain their melanogenic capacity when cultured in vitro. Melanotropic peptides such 
as a-melanocyte-stimulating hormone (a-MSH) induce formation and release of melanin pigment in B16-Fl cells. In contrast, Bl6-G4F cells do 
not respond to a-MSH. Using receptor-binding analysis and photoaffinity crosslinking we demonstrate that the lack of response of Bl6-G4F cells 
to a-MSH is due to the absence of functional MSH receptors from the cell surface. Northern blot analysis of receptor mRNA revealed that MSH 
receptor mRNA is not expressed in Bl6-G4F cells. These cells represent a new tool for the study of signal pathways related to the control of 
melanogenesis in melanoma cells. 
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1. INTRODUCTION 2.2. Tissue culture 
The Bl6-Fl and B16-G4F cell lines were maintained at 37°C in a 
humidified 95% sir/5% CO2 atmosphere using modified Eagle’s me- 
dium (MEM) with Earle’s salts (Gibco, Paisley, UK) supplemented 
with 10% heat-inactivated fetal calf serum (Amimed, Basel, Switzer- 
land), 2 mM L-glutamine (Gibco), 1% MEM non-essential amino acid 
solution (Gibco), 1% MEM vitamine solution (Gibco), 50 U/ml of 
penicillin and 50 ,&ml of streptomycin. 
Melanin pigments are produced in subcellular organ- 
elles, the melanosomes, which are distributed through- 
out the cytoplasm of melanocytes, and serve important 
physiological functions [ 1,2]. Intracellular melanin lev- 
els undergo alterations in response to various physio- 
logical stimuli [3]. However, the precise molecular 
mechanisms involved in skin pigmentation are still 
poorly understood. cx-MSH is a well known stimulator 
of melanogenesis n mammalian melanocytes and mela- 
noma cells and acts via the CAMP pathway on tyrosi- 
nase (EC 1.14.18.1) [4]. A specific membrane receptor 
for a-MSH has been characterized by structure-activity 
and binding studies [2] and by use of photoaffinity la- 
belling techniques [5,6,7]. Recently the cDNAs encod- 
ing the human and mouse MSH receptor genes have 
been cloned and sequenced [8, 91. This report presents 
evidence for the identification of a B 16 murine mela- 
noma subclone lacking MSH receptors. 
2. MATERIALS AND METHODS 2.5. Competition binding assays 
2.1. Chemicals 
a-MSH was a gift of Ciba-Geigy AG (Basel, Switzerland). The 
preparation of the radioligands ([‘2SI]Ty?,Nle4,0-Phe7)a-MSH and of 
photoreactive ([‘251]Ty?,Nle4,0-Phe7,Trp(Naps)9)a-MSH ([“‘I]Naps- 
MSH) was performed by the chloramine-T method as previously de- 
scribed [6]. All chemicals and solvents were of the highest purity 
available. 
The cell suspension was prepared at a density of 10’ cells/ml in 
modified Eagle’s medium with Earle’s salts (Gibco) containing 25 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 0.2% bovine 
serum albumine and 1 mM l,lO-phenanthroline (Merck, Darmstadt, 
Germany). Binding was initiated by adding 50 ~1 of ([‘251]Tyr2,Nle4,0- 
Phe’la-MSH to Eppendorf tubes containing 50 ~1 of [Nle4,0-Phe’]a- 
MSH peptide dilutions and 500 ~1 of cell suspension. For equilibrium 
binding the samples were incubated at 15°C for 3 h. Unbound radio- 
activity was removed by centrifugation through silicon oil. The bind- 
ing parameters were determined by Ligand, an iterative non-linear 
regression analysis program [1 11. 
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2.3. Bioassays 
The melanogenic response was determined with the in situ melanin 
assay as described previously [lo]. 
2.4. Photoaffinity labeling 
500 pl of cell suspension (10’ cells/ml) were incubated at 25°C 
together with 100 ~1 of a 2 nM [‘251]Naps-MSH solution in the pres- 
ence or absence of a 3000-fold excess of a-MSH. After 90 min, the 
samples were UV-irradiated on ice for 5 min, using the whole 310-550 
nm spectrum of a 1 kW Oriel mercury-xenon UV-irradiation appara- 
tus (irradiation intensity: 180 mW/cm*). Irradiated cells were exten- 
sively washed with cold 0.2% EDTA in PBS, pH 7.4. They were then 
lysed by resuspension in 2 mM Tris-HCl, pH 7.4, containing 0.3 mM 
1, IO-phenanthroline (15 min on ice) followed by homogenization. The 
pellets were resuspended in SDS-PAGE sample buffer and analyzed 
on gels as described previously [6]. 
2.6. Plasma membranes from BI6 cells 
Subconfluent monolayers were harvested with EDTA-PBS and 
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washed twice with PBS. Lysis of the cells was performed in 5 mM 
Tris-HCl, pH 7.4, containing 1 mM l,lO-phenanthroline. The homo- 
genate was centrifuged at 10,000 x g for 30 min. The resulting superna- 
tant was adjusted to 10 mM MgClz and further centrifuged at 
100,000 x g for 1 h at 4°C. The membranes were resuspended in 25 
mM Tris-HCI, pH 7.4, and the protein concentration was determined 
according to Lowry [12]. 
2.7. Adenylate cyclase activity assay 
Adenylate cyclase activity in B16-Fl and B16-G4F plasma mem- 
branes was determined using [LZ-~‘P]ATP as substrate. The reaction 
mixture (100 ~1 final volume) contained 25 mM Tris-HCI, pH 7.5, 1 
mM CAMP, 10 mM creatine phosphate, 0.25 ,@pl creatine kinase, 5 
mM MgCl,, 100 mM NaCl, 0.1 mM [a-“P]ATP (l-2 x lo6 cpm/assay), 
50 PM ATP, 50 PM GTP, 5 mM IBMX together with one of the 
adenylate cyclase agonists. Assays were initiated with the addition of 
60 pg plasma membranes and were incubated at 37°C for 15 min. 
Termination of the assay was achieved by the addition of 200~1 of 0.5 
N HCl. The samples were immersed in boiling water for 7 min, neu- 
tralized with 200 ~1 of 1.5 M imidazole and CAMP was quantified by 
the method of White [13]. 
2.8. Polymerase chain reaction 
The oligonucleotide primers were designed according to the pub- 
lished mouse MSH receptor cDNA sequence [9].The primer sequence 
at the S’end was 5’-ACAAGACTATGTCCACTC-3’ and at the 3’end 
5’-CAGGAAGGGATGAGTACC-3’. PCR was performed according 
to Saiki et al. [14]. Briefly, 1 pg of mouse genomic DNA was subjected 
to amplification in a 50 ~1 reaction mixture containing 10 mM Tris- 
HCl, pH 9, 50 mM KCl, 0.01% gelatin and 1.5 mM MgCl,. Sense and 
antisense primers were added at a concentration of 1 PM, followed by 
200pM of each dATP, dCTP, dTTP and dGTP (Pharmacia) with 0.25 
U of Taq Polymerase. The PCR profile used was 94°C for 60 s, 45°C 
for 40 s and 72°C for 60 s, using a thermal cycler (Perkin Elmer Cetus, 
USA). The PCR product was gel purified and subcloned in pBluescript 
SK- (Stratagene). The resulting plasmid was sequenced using the 
chain termination method [15] in order to confirm the DNA sequence. 
2.9. Northern analysis of mRNA 
Total mRNA was isolated using the guanidium thiocyanate method 
[16]. 10 pg of total RNA was subjected to electrophoresis through a 
1% formaldehyde agarose gel. The RNA was blotted on Hybond 
(Amersham). The hybridization was done for 16 h at 65’C in 0.5 M 
NaH,PO,, pH 7.2, containing 7% SDS, 1% BSA, 10 mM EDTA and 
the ‘*P-labelled MSH receptor probe. The membrane was then washed 
for 30 min in 2 x SSC and 0.1% SDS followed by 30 min in 0.1 x SSC 
and 0.1% SDS. The membrane was exposed to a autoradiographic film 
for 20 h at -7O’C. 
3. RESULTS AND DISCUSSION 
Terminal differentiation of B16-Fl cells in culture 
can be monitored by the production of melanin pig- 
ments [2,10]. While melanogenesis n the B16-Fl clone 
was stimulated by the addition of various concentra- 
tions of a-MSH, the results displayed in Fig. 1 show 
clearly that the hormone did not induce melanin pro- 
duction and release in the B16-G4F clone. This finding 
is in accordance with our previous results [17,18] which 
showed that a-MSH and ACTH did not stimulate ty- 
rosinase activity during the logarithmic growth phase of 
B16-G4F cells, indicating a possible impairment in the 
signal transduction pathway of these peptides. We sug- 
gested that the defect is located before the activation of 
protein kinase A since 2 mM theophylline could elicit 
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Fig. 1. Dose-response curves of B16 melanoma cell clones to a-MSH. 
The total melanin content of Bl6-Fl (0) and Bl6-G4F (0) cells was 
determined after 72 h of stimulation with serial dilutions of a-MSH 
in three independent experiments. 
a rise in tyrosinase activity. In order to identify the 
putative defect(s) in the MSH signal transduction ma- 
chinery we investigated CAMP production in B16-G4F 
cells as compared to B16-Fl cells. Adenylate cyclase 
activity in plasma membrane fractions from B 16-Fl 
was highly stimulated by 10m6 M a-MSH, 10m4 M fors- 
kolin and lo-* M sodium fluoride. The B16-G4F 
plasma membranes could also be stimulated by fors- 
kolin and NaF to produce CAMP, but not by a-MSH 
(Fig. 2). The lack of adenylate cyclase response to MSH 
is therefore clearly due to the absence of functional 
MSH receptors, since a functional 01, subunit of the 
heterotrimeric GTP-binding protein and adenylate 
cyclase must be present. This finding is further sup- 
ported by competition binding analysis using 
([‘251])Tyr2,Nle4,b-Phe7)&MSH as tracer and its non- 
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Fig. 2. Adenylate cyclase activity of B16 melanoma membranes after 
stimulation with various agonists. One unit of enzyme was defined as 
the amount catalyzing the formation of 1 pmole of cAMP/min. Results 
are expressed as the mean + standard deviation of quadruplicate de- 
terminations. 
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Fig. 3. Competition binding assays using constant amounts of 
([‘251]Tyr*,Nle4,0-Phe7]a-MSH and varying concentrations of [Nie4,0- 
Phe’]a-MSH as displacer. B16-Fl (0) and B16-G4F (0) cells were 
incubated for 3 h at 15°C in the presence of both peptides and un- 
bound radioactivity was determined as described in section 2. 
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iodinated form as displacer (Fig. 3). We have also per- 
formed photoaffinity labeling experiments using 
[‘ZSI]Naps-MSH as photoreactive probe [6] for the iden- 
tification of MSH receptors on the cell surface of B16- 
G4F cells. As shown in Fig. 4 our results corroborate 
the previous finding since no molecule could be identi- 
fied which had incorporated [‘*‘I]Naps-MSH after pho- 
toactivation. Furthermore we have analysed the MSH 
receptor mRNA of both cell lines by Northern blot 
analysis. A mouse MSH receptor probe was generated 
by PCR from the published cDNA sequence [9]. North- 




Fig. 4. Autoradiogram of an SDS-PAGE analysis of affinity-labelled 
B16 melanoma cells. Covalent labelling was achieved by incubating 
B16-G4F (1,2) and B16-Fl (3,4) cells with 0.2 pmoles of [“sI]Naps- 





Fig. 5. Northern blot analysis of MSH receptor transcripts in B16-Fl 
and Bl6-G4F cells. 1Opg of total mRNA was separated through a 1% 
formaldehyde agarose gel, blotted on Hybond (Amersham) and hy- 
bridized with the ‘*P-labelled mouse MSH receptor probe. Locations 
of 28 S and 18 S ribosomal RNA are indicated. 
transcript of -4kb. In contrast no MSH receptor mRNA 
was observed in B16-G4F cells (Fig. 5). 
Taken together these results show clearly that the 
lack of functional MSH receptors in B16-G4F is not 
caused by a mutated receptor protein but by the absence 
of expression of MSH receptor mRNA. Thus the B16- 
G4F melanoma cell clone will become a very useful tool 
for the study of signal pathways controlling melano- 
genesis. 
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